Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?

International Journal of Technology Assessment in Health Care

Volumn 25, Issue 2, 2009, Pages 222-231

  Shaukat, Aasma ^a   Parekh, Murtaza ^b   Lipscomb, Joseph ^c   Ladabaum, Uri ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Calcium; Chemoprevention; Colorectal cancer

Indexed keywords

CHEMOPREVENTION; COLONOSCOPY; COLORECTAL CANCER; INCREMENTAL COST; MARKOV MODEL; NATURAL HISTORY;

CALCIUM; COST EFFECTIVENESS; COSTS; MARKOV PROCESSES; MONITORING; TUMORS;

CALCIUM ALLOYS;

CALCIUM;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COST BENEFIT ANALYSIS; DRUG COST; FOLLOW UP; HUMAN; MODEL; POLYPECTOMY; POSTOPERATIVE CARE; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; TUMOR RECURRENCE; ADENOMA; AGED; COLON POLYP; COLORECTAL TUMOR; ECONOMICS; MIDDLE AGED;

ADENOMA; AGED; AGED, 80 AND OVER; CALCIUM; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HUMANS; MARKOV CHAINS; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS;

EID: 67549149223     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S026646230909028X     Document Type: Article

References (67)

1. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med. 2000;342:1156-1162.
2. Anderson WF, Umar A, Viner JL, Hawk ET. The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des. 2002;8:1035-1062. (Pubitemid 34498634)
3. Arguedas MR, Heudebert GR, Wilcox CM. Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: A decision analysis. Aliment Pharmacol Ther. 2001;15:631-638.
4. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group [see comment]. N Engl J Med. 1999;340:101-107.
5. Baron JA, Cole B F, Sandler RS, et. al. A randomized trial of aspirin to prevent colorectal adenomas [see comment]. N Engl J Med. 2003;348:891-899.
6. Bond JH. Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. Semin Gastrointest Dis. 2000;11:176-184. (Pubitemid 30797216)
7. Bond JH. Polyp guideline: Diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:3053-3063.
8. Bonithon-Kopp C, Piard F, Fenger C, et al. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323-333. (Pubitemid 38280584)
9. Brown ML, Riley GF, Potosky AL, Etzioni RD. Obtaining long-term disease specific costs of care: Application to Medicare enrollees diagnosed with colorectal cancer. Med Care. 1999;37:1249-1259.
10. Buckley LM, Hillner BE. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids [see comment]. J Rheumatol. 2003;30:132-138.
11. Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog. 1996;7:293-342. (Pubitemid 126453285)
12. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990;113:373-384.
13. Eddy DM, Nugent FW, Eddy JF, et al. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. Gastroenterology. 1987;92:682-692. (Pubitemid 17023731)
14. Fireman BH, Quesenberry CP, Somkin CP, et al. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev. 1997;18:51-76. (Pubitemid 27516400)
15. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Costeffectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954-1961. (Pubitemid 30778489)
16. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002;31:925-943. (Pubitemid 35403506)
17. Grau MV, Baron JA, Barry EL, et al. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2005;14:2353-11258
18. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med. 1994;331:141-147.
19. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
20. Hawk ET, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer. Surg Clin North Am. 2002;82:905-941.
21. Heaney RP, Dowell MS, Bierman J, Hale CA, Bendich A. Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr. 2001;20:239-246. (Pubitemid 32606171)
22. Itzkowitz SH. Gastrointestinal adenomatous polyps. Semin Gastrointest Dis. 1996;7:105-116.
23. Keller JL, Lanou A, Barnard ND. The consumer cost of calcium from food and supplements. J Am Diet Assoc. 2002;102:1669-1671. (Pubitemid 40434090)
24. Khandker RK, Dulski JD, Kilpatrick JB, et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care. 2000;16:799-810.
25. Ladabaum U, Chopra CL, Huang G, et al. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis. Ann Intern Med. 2001;135:769-781. (Pubitemid 33051261)
26. Ladabaum U, Scheiman JM, Fendrick AM. Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: A cost-effectiveness analysis. Am J Med. 2003;114:546-554. (Pubitemid 36577257)
27. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand [see comment]. Gastroenterology. 2005;129:1151-1162. (Pubitemid 41446855)
28. Ladabaum U, Song K, Fendrick AM. Colorectal neoplasia screening with virtual colonoscopy: When, at what cost, and with what national impact? Clin Gastroenterol Hepatol. 2004;2:554-563. (Pubitemid 38834039)
29. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms. Nat Rev Cancer. 2003;3:601-614. (Pubitemid 37328832)
30. Levenson DI, Bockman RS. A review of calcium preparations [erratum appears in Nutr Rev. 1994;52:364]. Nutr Rev. 1994;52:221-232.
31. Lipkin M. Early development of cancer chemoprevention clinical trials: Studies of dietary calcium as a chemopreventive agent for human subjects. Eur J Cancer Prev. 2002;11 (Suppl 2):S65-S70. (Pubitemid 35265865)
32. Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal cancer. Annu Rev Nutr. 1999;19:545-586. (Pubitemid 29380616)
33. Martinez ME, Sampliner R, Marshall JR, et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology. 2001;120:1077-1083. (Pubitemid 32246661)
34. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: A review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 1998;7:163-168.
35. Morson BC. The evolution of colorectal carcinoma. Clin Radiol. 1984;35:425-431.
36. National Center for Health Statistics. Preprint of Volume II, Mortality, Part A, Section 6 Life Tables. Hyattsville, MD: National Center for Health Statistics; 1998.
37. Neugut AI, Jacobson JS, Ahsan H, et al. Incidence and recurrence rates of colorectal adenomas: A prospective study. Gastroenterology. 1995;108:402-408.
38. Noshirwani KC, van Stolk RU, Rybicki LA, Beck GJ.Adenoma size and number are predictive of adenoma recurrence: Implications for surveillance colonoscopy. Gastrointest Endosc. 2000;51(pt 1):433-437.
39. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
40. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64.
41. Pence BC. Role of calcium in colon cancer prevention: Experimental and clinical studies. Mutat Res. 1993;290:87-95. (Pubitemid 23319760)
42. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349:2191-2200. (Pubitemid 37485135)
43. Red Book. Montvale: Thomson; 2008:840-843
44. Red Book. Montvale: Thomson; 2005:712-714
45. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24-28.
46. Ries LAG, Kosary CL, Hankey B, et al. SEER Cancer Statistics Review, 1973-1994. Bethesda, MD; National Cancer Institute; 1997:17-166.
47. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005;129:34-41. (Pubitemid 41002040)
48. Rosner AJ, Grima DT, Torrance GW, et al. Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis. Pharmacoeconomics. 1998;14:559-573.
49. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer [see comment][erratum appears in N Engl J Med. 2003;348:1939]. N Engl J Med. 2003;348;883-890.
50. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 2000;342:1149-1155.
51. Schoen RE. Surveillance after positive and negative colonoscopy examinations: Issues, yields, and use. Am J Gastroenterol. 2003;98:1237-1246.
52. Shaukat A, Scouras N, Schunemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: A metaanalysis of randomized controlled trials [see comment]. Am J Gastroenterol. 2005;100:390-394. (Pubitemid 40314524)
53. Slattery ML. Diet, lifestyle, and colon cancer. Semin Gastrointest Dis. 2000;11:142-146.
54. Song K, Fendrick AM, Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: A decision analysis. Gastroenterology. 2004;126:1270-1279. (Pubitemid 38552791)
55. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer.Ann InternMed. 2000;133:573-584. (Pubitemid 30778444)
56. Suleiman S, Rex DK, Sonnenberg A. Chemoprevention of colorectal cancer by aspirin: A cost-effectiveness analysis [see comment]. Gastroenterology. 2002;122:78-84. (Pubitemid 34049197)
57. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995;87(6):417-426.
58. Terry P, Baron JA, Bergkvist L, Holmberg L, Wolk A. Dietary calcium and vitamin D intake and risk of colorectal cancer: A prospective cohort study in women. Nutr Cancer. 2002;43:39-46. (Pubitemid 35387254)
59. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med. 2001;111:593-601. (Pubitemid 34088068)
60. Wactawski-Wende J, Kotchen JM, Anderson GL, et. al. Calcium plus vitamin D supplementation and the risk of colorectal cancer [see comment][erratum appears in N Engl J Med. 2006;354:1102]. N Engl J Med. 2006;354:684-696.
61. Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Costeffectiveness of colorectal cancer screening in average risk adults. In: Young G, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. Philadelphia: Saunders; 1996:321-356.
62. Wegener M, Borsch G, Schmidt G. Colorectal adenomas. Distribution, incidence of malignant transformation, and rate of recurrence. Dis Colon Rectum. 1986;29:383-387. (Pubitemid 16057745)
63. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology. 1997;112:594-642. (Pubitemid 27078848)
64. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544-560. (Pubitemid 36169269)
65. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-1981.
66. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328:901-906.
67. Zheng W, Anderson KE, Kushi LH, et al. A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1998;7:221-225.